Belite Bio Outperforms with Q4 GAAP EPS of -$0.25, Surpasses Estimates
Tuesday, 12 March 2024, 05:13
Belite Bio Q4 Earnings Report
Belite Bio press release stated that their Q4 GAAP EPS was -$0.25, surpassing expectations by $0.05. The company disclosed a significant cash reserve of $88.2 million as of December 31, 2023.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.